Advertisement
SAN DIEGO, April 28, 2016 /PRNewswire-iReach/ -- Joseph Lancman recently launched a campaign through Diabetes Research Connection (DRC) to fund his groundbreaking research to eliminate daily insulin injections for those living with type 1 diabetes, without removing original cells from the body. With a focus on innovative diabetes research, DRC's platform is perfect for funding early-career scientists like Lancman.
Photo - http://photos.prnewswire.com/prnh/20160427/361042Past research for eliminating daily insulin shots has faced many safety issues that Lancman and his lab crew have been searching to find away around. Lancman's recent breakthrough could allow scientists to convert nearly any cell type of their choice into replacement beta-cells for T1D patients, without having to remove them from the patient's body. This approach would bypass the need for invasive surgeries, bulky encapsulation devices and immunosuppressants."It's possible that we may have found a way to generate replacement beta-cells directly in people with T1D without removing the cells from the body, which has never been done before," says Lancman. "I'm grateful that DRC has made this research possible and allowed us to continue to dive deeper into our research that will, one day, cure T1D entirely."DRC ensures that one hundred percent of funds donated to Lancman's research goes directly to his lab, unlike other research funding facilities. Lancman's current work is the first of its kind and could help make the lives easier of those living with T1D. DRC encourages emerging scientists, like Lancman, with innovative diabetes research to apply through their website and work together to beat diabetes.For scientists looking to further their diabetes-related research, the DRC is currently accepting project submissions to be reviewed by more than 80 leading diabetes research experts through the website. All funding allocated to research for a scientists' project will go directly to their lab in order to further their research endeavors. Anyone can support Lancman's project, as well as other DRC-run projects, by making a tax-deductible donation. To learn more or to contribute to Lancman's project or the general DRC fund, visit www.diabetesresearchconnection.org.ABOUT DIABETES RESEARCH CONNECTIONThe Diabetes Research Connection is a 501(c)(3) non-profit organization headquartered in San Diego, California. Established in 2012 by five tireless proponents of diabetes research, our mission is to connect donors with early-career scientists enabling them to perform peer-reviewed novel research designed to prevent and cure type 1 diabetes, minimize its complications and improve the quality of life for those living with the disease. For more information, visit www.diabetesresearchconnection.org.
Media Contact: Stephanie Spaulding, Diabetes Research Connection, 919-414-2710, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Diabetes Research Connection
Advertisement
Photo - http://photos.prnewswire.com/prnh/20160427/361042Past research for eliminating daily insulin shots has faced many safety issues that Lancman and his lab crew have been searching to find away around. Lancman's recent breakthrough could allow scientists to convert nearly any cell type of their choice into replacement beta-cells for T1D patients, without having to remove them from the patient's body. This approach would bypass the need for invasive surgeries, bulky encapsulation devices and immunosuppressants."It's possible that we may have found a way to generate replacement beta-cells directly in people with T1D without removing the cells from the body, which has never been done before," says Lancman. "I'm grateful that DRC has made this research possible and allowed us to continue to dive deeper into our research that will, one day, cure T1D entirely."DRC ensures that one hundred percent of funds donated to Lancman's research goes directly to his lab, unlike other research funding facilities. Lancman's current work is the first of its kind and could help make the lives easier of those living with T1D. DRC encourages emerging scientists, like Lancman, with innovative diabetes research to apply through their website and work together to beat diabetes.For scientists looking to further their diabetes-related research, the DRC is currently accepting project submissions to be reviewed by more than 80 leading diabetes research experts through the website. All funding allocated to research for a scientists' project will go directly to their lab in order to further their research endeavors. Anyone can support Lancman's project, as well as other DRC-run projects, by making a tax-deductible donation. To learn more or to contribute to Lancman's project or the general DRC fund, visit www.diabetesresearchconnection.org.ABOUT DIABETES RESEARCH CONNECTIONThe Diabetes Research Connection is a 501(c)(3) non-profit organization headquartered in San Diego, California. Established in 2012 by five tireless proponents of diabetes research, our mission is to connect donors with early-career scientists enabling them to perform peer-reviewed novel research designed to prevent and cure type 1 diabetes, minimize its complications and improve the quality of life for those living with the disease. For more information, visit www.diabetesresearchconnection.org.
Media Contact: Stephanie Spaulding, Diabetes Research Connection, 919-414-2710, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Diabetes Research Connection
